期刊文献+

紫苏醇亚微乳剂对人乳腺癌细胞MCF-7增殖的抑制作用研究 被引量:2

Inhibition Effect of Perillyl Alcohol Sub-microemulsion on the Proliferation of Human Breast Cancer Cell MCF-7
原文传递
导出
摘要 目的:研究紫苏醇亚微乳剂对人乳腺癌细胞MCF-7的增殖抑制作用。方法:以紫苏醇溶液为对照,采用MTT比色法检测不同浓度(0、50、100、200、400、800μmol·L-1)紫苏醇亚微乳剂处理不同时间(24、48、72h)后对人乳腺癌细胞MCF-7的抑制率及半数抑制量(IC50)值,并设立空白组进行比较。结果:与空白组比较,试验组与对照组在作用24h、浓度高于400μmol·L-1,48h、浓度高于100μmol·L-1,72h、浓度高于50μmol·L-1时均表现出明显抑制作用(P<0.05);后2组抑制作用比较无显著性差异;试验组与对照组对MCF-7细胞株的IC50值分别为353.9、377.9μmol·L-1。结论:紫苏醇制成亚微乳剂后与其溶液比较,对人乳腺癌细胞MCF-7具有相同的抑制作用。 OBJECTIVE: To investigate inhibition effect of Perillyl alcohol sub-microemulsion on the proliferation of human breast cancer cell MCF-7. METHODS: The inhibition rates of MCF-7 by different concentrations of Perillyl alcohol sub-microemulsion (0 μmol·L^-1, 50μmol·L^-1, 100μmol·L^-1, 200μmol·L^-1, 400μmol·L^-1, 800 μmol·L^-1) at different time(24 h, 48 h, 72 h)were measured by MTT with Perillyl alcohol solution (POH-SOL) as control and compared with blank group. RESULTS: Compared with blank group, Perillyl alcohol sub-microemulsion and POH-SOL in trial group and control group showed obvious inhibition effect at concentration of more than 400μmol·L^-1 at 24 h, 100μmol·L^-1 at 48 h and 50 μmol·L^-1 at 72 h (P〈Z0.05). There was no significant difference between 2 groups. IC50 of trial group and control group to MCF-7 were 353.9 μmol·L^-1 and 377.9μmol·L^-1, respectively. CONCLUSION: Perillyl alcohol sub-microemulsion can inhibit the proliferation of human breast cancer cell MCF-7 as well as POH-SOL.
出处 《中国药房》 CAS CSCD 北大核心 2010年第45期4238-4239,共2页 China Pharmacy
基金 2009年河南省科技攻关重点基金资助项目(092102310028)
关键词 紫苏醇 亚微乳 人乳腺癌细胞MCF-7 MTT 增殖抑制 Perillyl alcohol Sub-microemulsion Human breast cancer cell MCF-7 MTT Inhibition effect of proliferation
  • 相关文献

参考文献5

  • 1韩丽,李福臣,刘洪富,苗光治,唐晓珍.紫苏的综合开发利用[J].食品研究与开发,2004,25(3):24-26. 被引量:68
  • 2Meadows SM, Mulkerin D, Berlin J, et al. Phase II trial of perillyl alcohol with metastatic colorectal cancer[J]. Int J Gastrointest Cancer, 2002, 32 (2 ~3 ) : 125.
  • 3Gupta A, Myrdal PB. Development of a perillyl alcohol topical cream formuation[J]. IntJPharm,2004,269(2):373.
  • 4Ripple GH, Gould MN, Stewart JA, et al. Phase I clinical trial ofperillyl alcohol administered daily[J]. Clin CancerRes, 1998,4(5):1 159.
  • 5Stark M J, Burke YD, McKinzie JH, et al. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol [J]. Cancer Letters, 1995,96 ( 1 ) : 15.

二级参考文献6

共引文献67

同被引文献15

  • 1国家中药管理局《中华本草》编委会.中华本草[M]第7卷.上海:上海科学技术出版社,1999:709-715.
  • 2Taylor D J, Parsons C E, Han H, et al. Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells [J]. BMC Cancer, 2011, 11: 470.
  • 3LEBEDEVA I V,SU Z,VOZHILLA N,et al.Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene7/interleuk in-24 and perillyl alcohol[J].Cancer Research,2008,68(18):7439-7447.
  • 4MEADOWS S M,MULKERIN D,BERLIN J,et al.Phase II trial of perillyl alcohol with metastatic colorectal cancer[J].International Journal of Gastrointestinal Cancer,2002,32(2/3):125-128.
  • 5BAILEY H H,ATTIA S,LOVE R R,et al.Phase II trial of daily oral perillyl alcohol(NSC 641066)in treatment-refractory metastatic breast cancer[J].Cancer Chemother Pharmacol,2008,62(1):149-157.
  • 6DA FONSECA C O,SCHWARTSMANN G,FISCHER J,et al.Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent maligant gliomas[J].Surgical Neurology,2008,70(3):259-267.
  • 7李询,罗军强,周捷,冯文彬,刘海洋,臧林泉.紫苏醇对肺癌细胞的体外药效作用及毒理学评价[J].广东药学院学报,2010,26(3):287-291. 被引量:3
  • 8何先元,许晋芳,王秋霜,陈媛媛.当归多糖的超声提取及含量测定[J].中国药业,2010,19(19):34-35. 被引量:25
  • 9塔西斯,张洁,杭永付,韩爱萍,丁选胜.北苍术炮制前后水提液和多糖部位保肝作用比较研究[J].现代中药研究与实践,2011,25(3):45-47. 被引量:24
  • 10梁存权.比色法测定植物多糖含量方法概述[J].北方药学,2011,8(12):4-4. 被引量:10

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部